SLNCR1 robust expression has been associated with worse overall melanoma survival; Schmidt et al. demonstrated that SLNCR1 bind to brain-specific homeobox protein 3a (Brn3a) and the androgen receptor (AR), constituting a complex with high affinity for the proximal MMP9 promoter. Here, LINC00511 is linked to melanoma.